Drug–Drug Interaction (DDI) Studies

  • In-Vitro CYP Induction/Inhibition Assays
  • Transporter Interaction Panels (P-gp, BCRP, OATP)
  • Follow-Up In-Vivo Confirmation Studies

Identifies metabolic and transporter-based drug–drug interactions, enabling early prediction and mitigation of clinical risks.

Scroll to Top